Takeda's Uloric Continues to Make Inroads among Moderate to Severe Gout ... - MarketWatch (press release) PDF Print
MarketWatch (press release)
Despite moderate to severe renal impairment being a contraindication for allopurinol, it is still prescribed for the majority of patients with renal impairment, regardless of severity. The one exception is rheumatologists who prescribe slightly more

...

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.